Scholarlink

<p>Vulvovaginal candidiasis (VVC) is a prevalent mucosal infection primarily caused by <i>Candida albicans</i>, affecting up to 75% of women of reproductive age. VVC therapeutic management is increasingly challenged by antifungal resistance, host toxicity, and high recurrence rates. <i>Lactobacillus</i> species, the dominant members of healthy vaginal microbiota, are known to antagonize pathogens and maintain mucosal homeostasis by producing antimicrobial metabolites and modulating epithelial responses. However, few studies have explored the antagonistic and anti-virulence properties of <i>Lactobacillus</i> strains isolated from asymptomatic women, particularly their activity against clinical <i>C. albicans</i> isolates. This study aimed to characterize vaginal <i>Lactobacillus</i> strains and their cell-free supernatants (CFS) isolated from asymptomatic women and evaluate their antifungal and anti-virulence activities against clinical isolates of <i>C. albicans</i>. Forty-two clinical <i>Lactobacillus</i> isolates were identified, of which eight inhibited the growth of the tested pathogens. However, among the clinical isolates, only <i>L. fermentum</i> JAC 231 and <i>Lactiplantibacillus plantarum</i> MDBL 269 inhibited all the fungal isolates tested. Based on these results, <i>L. fermentum</i> ATCC 23271 (positive control) and the clinical strains <i>L. fermentum</i> JAC 231 and <i>L. plantarum</i> MDBL 269 were selected for detailed analyses of their ability to interfere with key virulence factors of <i>C. albicans</i>, including hyphal morphogenesis, biofilm formation and disruption, adhesion, and the secretion of extracellular enzymes. The selected strains and their CFS displayed antagonistic activity: they reduced pathogen adhesion, co-aggregated with yeast cells, impaired biofilm formation, and destabilized preformed biofilms. In addition, whole-genome sequencing combined with antimicrobial peptide gene-cluster prediction using BAGEL4 and antiSMASH revealed two biosynthetic gene clusters in <i>L. fermentum</i> JAC 231 and seven in <i>L. plantarum</i> MDBL 269, providing a plausible genetic basis for the antimicrobial effects observed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anti-Candida albicans and anti-virulence activities of vaginal Lactobacillus strains from asymptomatic women: phenotypic characterization and prediction of antimicrobial peptide gene clusters

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月29日

查看全文
  • Carmem Duarte Lima Campos,
  • Camila Itapary Dos Santos,
  • Ennio Patrezzi Sousa Costa,
  • Amanda Graziela Gonçalves Mendes,
  • Cinara Regina Aragão Vieira Monteiro,
  • Eduarda Gomes Bogéa,
  • Paulo Xavier de Castro Moreira,
  • Patrícia Cristina Ribeiro Conceição,
  • Sirlei Garcia Marques,
  • Julliana Ribeiro Alves dos Santos,
  • Mayara Cristina Pinto da Silva,
  • Cristina de Andrade Monteiro,
  • Valério Monteiro-Neto

摘要

Vulvovaginal candidiasis (VVC) is a prevalent mucosal infection primarily caused by Candida albicans, affecting up to 75% of women of reproductive age. VVC therapeutic management is increasingly challenged by antifungal resistance, host toxicity, and high recurrence rates. Lactobacillus species, the dominant members of healthy vaginal microbiota, are known to antagonize pathogens and maintain mucosal homeostasis by producing antimicrobial metabolites and modulating epithelial responses. However, few studies have explored the antagonistic and anti-virulence properties of Lactobacillus strains isolated from asymptomatic women, particularly their activity against clinical C. albicans isolates. This study aimed to characterize vaginal Lactobacillus strains and their cell-free supernatants (CFS) isolated from asymptomatic women and evaluate their antifungal and anti-virulence activities against clinical isolates of C. albicans. Forty-two clinical Lactobacillus isolates were identified, of which eight inhibited the growth of the tested pathogens. However, among the clinical isolates, only L. fermentum JAC 231 and Lactiplantibacillus plantarum MDBL 269 inhibited all the fungal isolates tested. Based on these results, L. fermentum ATCC 23271 (positive control) and the clinical strains L. fermentum JAC 231 and L. plantarum MDBL 269 were selected for detailed analyses of their ability to interfere with key virulence factors of C. albicans, including hyphal morphogenesis, biofilm formation and disruption, adhesion, and the secretion of extracellular enzymes. The selected strains and their CFS displayed antagonistic activity: they reduced pathogen adhesion, co-aggregated with yeast cells, impaired biofilm formation, and destabilized preformed biofilms. In addition, whole-genome sequencing combined with antimicrobial peptide gene-cluster prediction using BAGEL4 and antiSMASH revealed two biosynthetic gene clusters in L. fermentum JAC 231 and seven in L. plantarum MDBL 269, providing a plausible genetic basis for the antimicrobial effects observed.